CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Adipsin was demonstrated a non-significant (p≤0.08) lower expression in CML, in comparison with the other groups in the total BM fraction; however, cyclin D3 experienced a higher expression (p≤0.08) in CML in the CD34+ve fraction.